
Nov 20, 2026 · 2 min read · Incretin Analogs
Semaglutide and Muscle Function in Obese Mice
In obese mice, semaglutide produced more weight loss than energy-matched caloric restriction without impairing muscle function.
EvoX Biolabs sells research compounds for laboratory use only. You must be 21 or older to enter.
For research use only. Not for human or animal consumption.
For research use only. Not for human or animal consumption. Ships to US addresses only.

Nov 20, 2026 · 2 min read · Incretin Analogs
In obese mice, semaglutide produced more weight loss than energy-matched caloric restriction without impairing muscle function.
Nov 20, 2026 · 2 min read · Industry News
Ascletis submitted a US IND for ASC36_37o, a once-weekly oral amylin plus GLP-1/GIP/glucagon peptide combination. Data so far are preclinical.

Nov 20, 2026 · 2 min read · Incretin Analogs
STEP Young, a phase 3 NEJM trial in 167 children aged 6 to <12, reported BMI change of -13.5% with semaglutide vs +2.7% with placebo at week 68.

Nov 16, 2026 · 3 min read · Incretin Analogs
Phase 3b REDEFINE 9 (Lancet Diabetes & Endocrinology): about 21% mean weight change at 68 weeks vs 2.0% with placebo in 309 adults.